Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Geltex
Approval Status: Approved November 1998
Treatment for: Urology

General Information

Nonabsorbed, oral, phosphate binding polymer hydrogel for the control of hyperphosphatemia in patients with end stage renal disease.

Mechanism of Action

The agent acts by binding phosphorus in the gastrointestinal tract and allows elimination of phosphorus through normal digestive processes.